sivelestat has been researched along with Mucocutaneous Lymph Node Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banno-Terada, R; Endo, M; Fujii, T; Kohno, T; Maekawa, A; Mamiya, R; Nagi-Miura, N; Ohno, N; Takada, M; Takagaki, N; Tanaka, A; Tsuji, T; Yamada, A; Yoshida, Y | 1 |
| Ebata, R; Hamada, H; Hanaoka, H; Higashi, K; Homma, J; Kobayashi, H; Kohno, Y; Nagai, K; Okunushi, K; Saito, N; Saito, Y; Shimojo, N; Takada, N; Takechi, F; Yasukawa, K | 1 |
1 trial(s) available for sivelestat and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Sivelestat sodium hydrate treatment for refractory Kawasaki disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Glycine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Male; Mucocutaneous Lymph Node Syndrome; Pilot Projects; Prospective Studies; Serine Proteinase Inhibitors; Sulfonamides; Treatment Outcome | 2019 |
1 other study(ies) available for sivelestat and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis.
Topics: Animals; Candida albicans; Glycine; Humans; Intercellular Adhesion Molecule-1; Mice; Mucocutaneous Lymph Node Syndrome; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha; Vasculitis | 2022 |